Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-014859
Filing Date
2024-11-07
Accepted
2024-11-07 16:06:33
Documents
82
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zom-20240930x10q.htm   iXBRL 10-Q 2050559
2 EX-10.3 zom-20240930xex10d3.htm EX-10.3 109240
3 EX-10.4 zom-20240930xex10d4.htm EX-10.4 93051
4 EX-10.5 zom-20240930xex10d5.htm EX-10.5 94331
5 EX-31.1 zom-20240930xex31d1.htm EX-31.1 11851
6 EX-31.2 zom-20240930xex31d2.htm EX-31.2 12673
7 EX-32.1 zom-20240930xex32d1.htm EX-32.1 11128
  Complete submission text file 0001558370-24-014859.txt   10482174

Data Files

Seq Description Document Type Size
8 EX-101.SCH zom-20240930.xsd EX-101.SCH 44460
9 EX-101.CAL zom-20240930_cal.xml EX-101.CAL 78579
10 EX-101.DEF zom-20240930_def.xml EX-101.DEF 167263
11 EX-101.LAB zom-20240930_lab.xml EX-101.LAB 452998
12 EX-101.PRE zom-20240930_pre.xml EX-101.PRE 338800
85 EXTRACTED XBRL INSTANCE DOCUMENT zom-20240930x10q_htm.xml XML 2497599
Mailing Address 100 PHOENIX DRIVE SUITE 125 ANN ARBOR MI 48108
Business Address 100 PHOENIX DRIVE SUITE 125 ANN ARBOR MI 48108 (734) 369-2555
Zomedica Corp. (Filer) CIK: 0001684144 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38298 | Film No.: 241435574
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)